10.57
price up icon2.92%   0.30
after-market Handel nachbörslich: 10.59 0.02 +0.19%
loading
Schlusskurs vom Vortag:
$10.27
Offen:
$10.19
24-Stunden-Volumen:
771.14K
Relative Volume:
0.68
Marktkapitalisierung:
$1.60B
Einnahmen:
$58.44M
Nettoeinkommen (Verlust:
$-80.74M
KGV:
-8.8083
EPS:
-1.2
Netto-Cashflow:
$-76.32M
1W Leistung:
-6.46%
1M Leistung:
+7.42%
6M Leistung:
+71.31%
1J Leistung:
+224.23%
1-Tages-Spanne:
Value
$10.07
$10.66
1-Wochen-Bereich:
Value
$9.76
$11.48
52-Wochen-Spanne:
Value
$1.995
$11.78

Ocular Therapeutix Inc Stock (OCUL) Company Profile

Name
Firmenname
Ocular Therapeutix Inc
Name
Telefon
781-357-4000
Name
Adresse
15 CROSBY DRIVE, BEDFORD, MA
Name
Mitarbeiter
267
Name
Twitter
@OCUTX
Name
Nächster Verdiensttermin
2024-11-05
Name
Neueste SEC-Einreichungen
Name
OCUL's Discussions on Twitter

Ocular Therapeutix Inc Stock (OCUL) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-04-21 Eingeleitet Robert W. Baird Outperform
2022-08-10 Fortgesetzt Berenberg Buy
2021-08-10 Hochstufung H.C. Wainwright Neutral → Buy
2020-12-28 Herabstufung H.C. Wainwright Buy → Neutral
2020-12-17 Eingeleitet Berenberg Buy
2020-11-13 Bestätigt Raymond James Strong Buy
2020-08-10 Bestätigt H.C. Wainwright Buy
2020-03-03 Hochstufung Raymond James Outperform → Strong Buy
2019-05-21 Herabstufung Cowen Outperform → Market Perform
2019-05-21 Bestätigt H.C. Wainwright Buy
2019-05-21 Herabstufung Raymond James Strong Buy → Outperform
2018-12-03 Bestätigt Cantor Fitzgerald Overweight
2018-11-15 Eingeleitet Raymond James Strong Buy
2018-09-07 Eingeleitet Piper Jaffray Overweight
2017-10-24 Eingeleitet Guggenheim Buy
2017-07-26 Eingeleitet H.C. Wainwright Buy
2017-07-12 Bestätigt Cantor Fitzgerald Overweight
2017-06-23 Herabstufung Morgan Stanley Overweight → Equal-Weight
2017-02-10 Eingeleitet Cantor Fitzgerald Overweight
2016-11-15 Bestätigt RBC Capital Mkts Outperform
2016-08-11 Eingeleitet JMP Securities Mkt Outperform
2016-02-17 Hochstufung Morgan Stanley Equal-Weight → Overweight
2015-10-23 Herabstufung Morgan Stanley Overweight → Equal-Weight
2015-08-13 Eingeleitet Morgan Stanley Overweight
Alle ansehen

Ocular Therapeutix Inc Aktie (OCUL) Neueste Nachrichten

pulisher
03:30 AM

Vanguard Group Inc's Strategic Reduction in Ocular Therapeutix I - GuruFocus.com

03:30 AM
pulisher
Nov 02, 2024

Ocular Therapeutix, Inc. (NASDAQ:OCUL) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Nov 02, 2024
pulisher
Oct 28, 2024

Ocular Therapeutix stock soars to 52-week high of $11.64 By Investing.com - Investing.com South Africa

Oct 28, 2024
pulisher
Oct 28, 2024

Ocular Therapeutix (NASDAQ:OCUL) Reaches New 1-Year HighHere's What Happened - MarketBeat

Oct 28, 2024
pulisher
Oct 28, 2024

Ocular Therapeutix stock soars to 52-week high of $11.64 - Investing.com India

Oct 28, 2024
pulisher
Oct 28, 2024

Short Interest in Ocular Therapeutix, Inc. (NASDAQ:OCUL) Drops By 18.1% - MarketBeat

Oct 28, 2024
pulisher
Oct 26, 2024

Assenagon Asset Management S.A. Makes New Investment in Ocular Therapeutix, Inc. (NASDAQ:OCUL) - MarketBeat

Oct 26, 2024
pulisher
Oct 21, 2024

Neuropathic Ocular Pain Pipeline Assessment 2024: Therapies, - openPR

Oct 21, 2024
pulisher
Oct 21, 2024

Neuropathic Ocular Pain Pipeline Assessment 2024: Therapies, Clinical Trials, Therapies, and Key Companies Involved by DelveInsight | Ocular Therapeutix, Aldeyra Therapeutics, Aciex Therapeutics - Barchart

Oct 21, 2024
pulisher
Oct 21, 2024

Allergic Conjunctivitis Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies, and Key Companies Involved by DelveInsight | Bausch & Lomb Inc, Aldeyra Therapeutics, Vanda Pharma, OKYO - The Globe and Mail

Oct 21, 2024
pulisher
Oct 20, 2024

Ocular Therapeutix (OCUL) Moves 6.1% Higher: Will This Strength Last? - MSN

Oct 20, 2024
pulisher
Oct 20, 2024

HC Wainwright Reaffirms “Buy” Rating for Ocular Therapeutix (NASDAQ:OCUL) - Defense World

Oct 20, 2024
pulisher
Oct 18, 2024

SG Americas Securities LLC Purchases Shares of 45,187 Ocular Therapeutix, Inc. (NASDAQ:OCUL) - MarketBeat

Oct 18, 2024
pulisher
Oct 17, 2024

Ocular Therapeutix (NASDAQ:OCUL) Sets New 52-Week HighTime to Buy? - MarketBeat

Oct 17, 2024
pulisher
Oct 16, 2024

Ocular Therapeutix stock soars to 52-week high of $11.34 - Investing.com

Oct 16, 2024
pulisher
Oct 16, 2024

Ocular Therapeutix stock soars to 52-week high of $11.34 By Investing.com - Investing.com UK

Oct 16, 2024
pulisher
Oct 16, 2024

Is Ocular Therapeutix (NASDAQ:OCUL) Weighed On By Its Debt Load? - Simply Wall St

Oct 16, 2024
pulisher
Oct 16, 2024

Ocular Therapeutix (NASDAQ:OCUL) Stock Price Up 4.9%Here's Why - MarketBeat

Oct 16, 2024
pulisher
Oct 16, 2024

Ocular Therapeutix shares hold as analyst reiterates Buy rating By Investing.com - Investing.com UK

Oct 16, 2024
pulisher
Oct 16, 2024

Ocular Therapeutix Inc (OCUL) expanding its growth trajectory ahead - SETE News

Oct 16, 2024
pulisher
Oct 16, 2024

Ocular Therapeutix (NASDAQ:OCUL) Coverage Initiated at Scotiabank - MarketBeat

Oct 16, 2024
pulisher
Oct 16, 2024

Ocular Therapeutix (NASDAQ:OCUL) Earns "Buy" Rating from HC Wainwright - MarketBeat

Oct 16, 2024
pulisher
Oct 15, 2024

Ocular Therapeutix speeds up wet AMD trial enrollment - Investing.com

Oct 15, 2024
pulisher
Oct 15, 2024

Taking a Closer Look At Ocular Therapeutix Inc (OCUL) Following Its Recent Trade - Knox Daily

Oct 15, 2024
pulisher
Oct 15, 2024

Ocular Therapeutix speeds up wet AMD trial enrollment By Investing.com - Investing.com South Africa

Oct 15, 2024
pulisher
Oct 15, 2024

Ocular Therapeutix™ Announces Accelerated Timelines for SOL-1 Registrational Trial of AXPAXLI™ in Wet AMD - GlobeNewswire

Oct 15, 2024
pulisher
Oct 15, 2024

Ocular Therapeutix Inc (OCUL) Stock: A Year of Market Fluctuations - The InvestChronicle

Oct 15, 2024
pulisher
Oct 14, 2024

What is the investor’s view on Ocular Therapeutix Inc (OCUL)? - US Post News

Oct 14, 2024
pulisher
Oct 13, 2024

Ocular Therapeutix: Focus On Axpaxli's Path To Market In Wet-AMD And Implications To Investors - Seeking Alpha

Oct 13, 2024
pulisher
Oct 11, 2024

Ocular Therapeutix Inc [OCUL] stock for 16,525 USD was sold by Nayak Sanjay - Knox Daily

Oct 11, 2024
pulisher
Oct 10, 2024

Amendment to 2019 Inducement Stock Incentive Plan Boosts Ocular Therapeutix’s Shares - MarketBeat

Oct 10, 2024
pulisher
Oct 09, 2024

Ocular Therapeutix expands stock incentive plan - Investing.com India

Oct 09, 2024
pulisher
Oct 09, 2024

Ocular Therapeutix expands stock incentive plan By Investing.com - Investing.com South Africa

Oct 09, 2024
pulisher
Oct 09, 2024

Ocular Therapeutix Expands Stock Incentive Plan for Employees - TipRanks

Oct 09, 2024
pulisher
Oct 09, 2024

Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Oct 09, 2024
pulisher
Oct 09, 2024

Ocular Therapeutix : Amendment No. 4 to 2019 Inducement Stock Incentive Plan Form 8 K - Marketscreener.com

Oct 09, 2024
pulisher
Oct 09, 2024

Market Momentum Report: Ocular Therapeutix Inc (OCUL)’s Negative Close at 9.32 - The Dwinnex

Oct 09, 2024
pulisher
Oct 09, 2024

Ocular Therapeutix Inc (OCUL) Performance and Fundamentals Dashboard tells a completely different story - SETE News

Oct 09, 2024
pulisher
Oct 09, 2024

Ocular Therapeutix™ to Present at October Ophthalmology Meetings - The Manila Times

Oct 09, 2024
pulisher
Oct 08, 2024

Here's What Could Help Ocular Therapeutix (OCUL) Maintain Its Recent Price Strength - Yahoo Finance

Oct 08, 2024
pulisher
Oct 08, 2024

What was Ocular Therapeutix Inc (OCUL)’s performance in the last session? - US Post News

Oct 08, 2024
pulisher
Oct 08, 2024

Brokerages Set Ocular Therapeutix, Inc. (NASDAQ:OCUL) PT at $15.67 - MarketBeat

Oct 08, 2024
pulisher
Oct 05, 2024

Objective long/short (OCUL) Report - Stock Traders Daily

Oct 05, 2024
pulisher
Oct 04, 2024

Marshall Wace LLP Purchases New Shares in Ocular Therapeutix, Inc. (NASDAQ:OCUL) - MarketBeat

Oct 04, 2024
pulisher
Oct 03, 2024

Technical analysis of Ocular Therapeutix Inc (OCUL) stock chart patterns - US Post News

Oct 03, 2024
pulisher
Oct 02, 2024

Potential Price Increase for Ocular Therapeutix Inc (OCUL) After Recent Insider Activity - Knox Daily

Oct 02, 2024
pulisher
Oct 01, 2024

Daily Market Movement: Ocular Therapeutix Inc (OCUL) Sees a 0.23 Increase, Closing at 8.70 - The Dwinnex

Oct 01, 2024
pulisher
Oct 01, 2024

Nantahala Capital Management LLC Buys Shares of 1,000,000 Ocular Therapeutix, Inc. (NASDAQ:OCUL) - MarketBeat

Oct 01, 2024
pulisher
Sep 30, 2024

Investors in cash trouble should check out Ocular Therapeutix Inc (OCUL) - SETE News

Sep 30, 2024
pulisher
Sep 30, 2024

Ocular Therapeutix's SWOT analysis: stock poised for growth amid retina focus shift - Investing.com

Sep 30, 2024
pulisher
Sep 30, 2024

Second Line Capital LLC Buys New Position in Ocular Therapeutix, Inc. (NASDAQ:OCUL) - MarketBeat

Sep 30, 2024

Finanzdaten der Ocular Therapeutix Inc-Aktie (OCUL)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Kapitalisierung:     |  Volumen (24h):